215380 — Woojung BIO Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Woojung BIO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	6,746	4,820	5,566	4,268	3,939
Net Total Accounts Receivable
Net Total Receivables	5,758	2,149	7,181	6,029	4,008
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	25,169	13,887	19,690	19,928	17,135
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	57,281	63,715	56,130	51,581	47,463
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	100,136	94,994	98,333	94,699	86,795
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	38,010	45,244	45,699	31,348	30,068
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	68,676	65,275	76,361	65,326	63,417
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	31,460	29,718	21,972	29,373	23,378
Total Liabilities & Shareholders' Equity	100,136	94,994	98,333	94,699	86,795
Total Common Shares Outstanding
Total Preferred Shares Outstanding